A5089514155- GDF15 and Related Biomarkers
- Alzheimer's disease research and treatments
- RNA modifications and cancer
- Bipolar Disorder and Treatment
- Congenital Anomalies and Fetal Surgery
- Diet and metabolism studies
- Neurogenetic and Muscular Disorders Research
- Peptidase Inhibition and Analysis
- Diabetes Management and Research
IRCCS Eugenio Medea
2022
University of Bari Aldo Moro
2022
University of Molise
2017
Alzheimer's disease (AD) is a progressive, multifactorial neurodegenerative disorder that the main cause of dementia. To date, there are no definitive diagnostic tests can predict or assess onset and progression disease. Blood biomarkers for AD being sought many years but ir identification remains challenging task. In this study, we investigated potential relationship between levels acyl-peptide hydrolase (APEH) proteasome in erythrocyte samples 52 participants (26 26 cognitively healthy...
Psychiatric disorders are associated with cardiometabolic diseases, partly due to adverse drug effects individual risk variabilities. Risperidone and sertraline widely used for youths. Although they may be exposed anthropometric changes, few data about this population exist. We evaluated the correlation between several blood parameters body changes in a very small group of drug-naïve adolescents who had started risperidone or sertraline. examined weight, waist circumference (WC), WC/height...